Patent Assignment
Reel/Frame 045075/0423
Change of Name
Recorded: 2018-01-16
Pages: 20
Assignor
RIBOPHARMA AG
Executed: 2004-05-27
Assignee
ALNYLAM EUROPE AG
FRITZ-HORNSCHUCH-STR. 9, KULMBACH, 95326, GERMANY
Covered Property
(1)
Method and Medicament For Inhibiting The Expression of A Given Gene
Application:
15/870,380 →
Publication:
US 2018/0179526
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.